Clinical Trials Logo

Ampulla of Vater Adenoma clinical trials

View clinical trials related to Ampulla of Vater Adenoma.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT01737463 Enrolling by invitation - Clinical trials for Ampulla of Vater Adenoma

Prophylactic Pancreatic Duct Stent Placement After ESP of Major Papillary Tumors; Prospective, Randomized Study

PDS
Start date: March 2010
Phase: Phase 4
Study type: Interventional

Endoscopic snare papillectomy (ESP) is an efficient treatment for benign tumors of the duodenal major papilla. But post-ESP pancreatitis is the most common and serious complication. Since one prospective randomized controlled trial showed that pancreatic duct stent placement reduced post-ESP pancreatitis, almost physicians have tried to place the pancreatic duct stent after EPS. The aim of this prospective, randomized, multicenter trial is to compare the rates of post-ESP pancreatitis in patients who did or did not prophylactic pancreatic duct stent placement. Consecutive patients who were to undergo ESP were to randomized to pancreatic duct stent placement group (stent group) after endoscopic snare papillectomy or to no pancreatic duct stent placement group (no stent group).